Menu
Back to User profile » Dr Taku Nakagami
Papers published by Dr Taku Nakagami:
Dietary patterns and schizophrenia: a comparison with healthy controls
Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2015, 11:1115-1120
Published Date: 22 April 2015
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:997-998
Published Date: 5 June 2014
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:599-606
Published Date: 8 April 2014
Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:427-432
Published Date: 28 February 2014
Interaction between paliperidone extended release and TS-1®, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
Yasui-Furukori N, Hashimoto K, Kubo K, Tomita T
Neuropsychiatric Disease and Treatment 2013, 9:317-320
Published Date: 3 March 2013